Peter H. Bui, Ph.D. - Publications

Affiliations: 
2009 University of California, Los Angeles, Los Angeles, CA 
Area:
Toxicology

9/16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Bui P, Solaimani P, Wu X, Hankinson O. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicology and Applied Pharmacology. 259: 143-51. PMID 22230337 DOI: 10.1016/J.Taap.2011.12.009  0.722
2012 Bebenek IG, Solaimani P, Bui P, Hankinson O. CYP2S1 is negatively regulated by corticosteroids in human cell lines. Toxicology Letters. 209: 30-4. PMID 22155357 DOI: 10.1016/J.Toxlet.2011.11.020  0.664
2011 Quesada A, Bui PH, Homanics GE, Hankinson O, Handforth A. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor. European Journal of Pharmacology. 659: 30-6. PMID 21256842 DOI: 10.1016/J.Ejphar.2011.01.004  0.634
2011 Bui P, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O. Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 180-90. PMID 21068195 DOI: 10.1124/Dmd.110.035121  0.712
2010 Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW, Hankinson O. Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes. Molecular Pharmacology. 78: 608-16. PMID 20631054 DOI: 10.1124/Mol.110.064899  0.725
2009 Bui PH, Hankinson O. Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Molecular Pharmacology. 76: 1031-43. PMID 19713358 DOI: 10.1124/Mol.109.057752  0.715
2009 Bui PH, Hsu EL, Hankinson O. Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Molecular Pharmacology. 76: 1044-52. PMID 19713357 DOI: 10.1124/Mol.109.057760  0.738
2009 Beedanagari SR, Bebenek I, Bui P, Hankinson O. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicological Sciences : An Official Journal of the Society of Toxicology. 110: 61-7. PMID 19376845 DOI: 10.1093/Toxsci/Kfp079  0.658
2008 Bui PH, Quesada A, Handforth A, Hankinson O. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1291-9. PMID 18411403 DOI: 10.1124/Dmd.107.020115  0.615
Low-probability matches (unlikely to be authored by this person)
2013 Amarillo I, Bui PH, Kantarci S, Rao N, Shackley BS, García R, Tirado CA. Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression. Molecular Cytogenetics. 6: 5. PMID 23369149 DOI: 10.1186/1755-8166-6-5  0.236
2013 Bui PH, Dorrani N, Wong D, Perens G, Dipple KM, Quintero-Rivera F. First report of a de novo 18q11.2 microdeletion including GATA6 associated with complex congenital heart disease and renal abnormalities. American Journal of Medical Genetics. Part A. 161: 1773-8. PMID 23696469 DOI: 10.1002/Ajmg.A.35974  0.23
2013 Logan JE, Mostofizadeh N, Desai AJ, VON Euw E, Conklin D, Konkankit V, Hamidi H, Eckardt M, Anderson L, Chen HW, Ginther C, Taschereau E, Bui PH, Christensen JG, Belldegrun AS, et al. PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity. Anticancer Research. 33: 2997-3004. PMID 23898052  0.121
2021 Thompson J, Salter J, Bui P, Herbert L, Mills D, Wagner D, Brent C. Safety, Efficacy, and Cost of 0.4-mg Versus 2-mg Intranasal Naloxone for Treatment of Prehospital Opioid Overdose. The Annals of Pharmacotherapy. 10600280211030918. PMID 34229467 DOI: 10.1177/10600280211030918  0.056
2008 Brown J, Kuo I, Bellows J, Barry R, Bui P, Wohlgemuth J, Wills E, Parikh N. Patient perceptions and acceptance of routine emergency department HIV testing. Public Health Reports (Washington, D.C. : 1974). 123: 21-6. PMID 19172703  0.045
2009 Bui P, Demian N, Beetar P. Infection rate in mandibular angle fractures treated with a 2.0-mm 8-hole curved strut plate. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 67: 804-8. PMID 19304038 DOI: 10.1016/j.joms.2008.08.034  0.041
2009 Bui P, Ivan D, Oliver D, Busaidy KF, Wilson J. Chondroblastoma of the temporomandibular joint: report of a case and literature review. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 67: 405-9. PMID 19138618 DOI: 10.1016/j.joms.2008.01.043  0.01
Hide low-probability matches.